Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-06-25 Sale |
2024-06-26 4:26 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Fitzgerald Kevin Joseph CSO & EVP, Head of Research |
1,198 | $230.99 | $276,731 | 14,718 (Indirect Direct) |
View |
| 2024-05-29 Sale |
2024-05-31 7:00 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | SCHULMAN AMY W Director |
21,700 | $148.6 | $3,224,546 | 8,436 (Direct) |
View |
| 2024-02-29 Sale |
2024-03-01 4:12 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | SHARP PHILLIP A Director |
30,000 | $151.34 | $4,540,071 | 266,899 (Indirect Direct) |
View |
| 2024-02-28 Sale |
2024-02-29 4:18 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Tanguler Tolga EVP, Chief Commercial Officer |
501 | $155.3 | $77,805 | 8,569 (Direct) |
View |
| 2024-02-28 Sale |
2024-02-29 4:18 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer |
574 | $155.3 | $89,145 | 23,351 (Indirect Direct) |
View |
| 2024-02-28 Sale |
2024-02-29 4:18 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer |
2,932 | $155.31 | $455,357 | 60,377 (Indirect Direct) |
View |
| 2024-02-28 Sale |
2024-02-29 4:17 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs |
574 | $155.3 | $89,145 | 13,163 (Indirect Direct) |
View |
| 2024-02-28 Sale |
2024-02-29 4:16 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Franchini Indrani Lall EVP, CLO & Secretary |
329 | $155.3 | $51,094 | 5,887 (Direct) |
View |
| 2024-02-16 Sale |
2024-02-20 4:09 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs |
1,308 | $148.06 | $193,666 | 8,013 (Indirect Direct) |
View |
| 2024-02-16 Sale |
2024-02-20 4:08 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer |
1,007 | $148.06 | $149,099 | 18,201 (Indirect Direct) |
View |
| 2024-02-16 Sale |
2024-02-20 4:08 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Tanguler Tolga EVP, Chief Commercial Officer |
1,009 | $148.06 | $149,397 | 4,070 (Direct) |
View |
| 2024-02-16 Sale |
2024-02-20 4:07 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer |
7,030 | $148.06 | $1,040,885 | 45,546 (Indirect Direct) |
View |
| 2024-02-02 Sale |
2024-02-05 4:05 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Franchini Indrani Lall EVP, CLO & Secretary |
1,591 | $170.99 | $272,050 | 8,759 (Direct) |
View |
| 2023-12-27 Sale |
2023-12-29 4:03 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | BONNEY MICHAEL W Director |
30,000 | $195 | $5,850,000 | 20,029 (Indirect Direct) |
View |
| 2023-08-04 Sale |
2023-08-07 6:05 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs |
7,627 | $184.78 | $1,409,306 | 5,026 (Indirect Direct) |
View |
| 2023-08-04 Sale |
2023-08-07 6:05 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer |
3,460 | $185.85 | $643,037 | 15,930 (Indirect Direct) |
View |
| 2023-08-04 Sale |
2023-08-07 6:04 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer |
4,057 | $185.85 | $753,986 | 35,623 (Indirect Direct) |
View |
| 2023-08-04 Sale |
2023-08-07 6:04 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Vaishnaw Akshay President |
4,057 | $185.85 | $753,986 | 23,289 (Indirect Direct) |
View |
| 2023-08-03 Sale |
2023-08-04 4:02 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | BONNEY MICHAEL W Director |
6,448 | $185.38 | $1,195,310 | 20,029 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-06-24 Option Award |
2024-06-26 4:26 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Fitzgerald Kevin Joseph CSO & EVP, Head of Research |
2,498 | $0 | 14,718 (Direct) |
View |
| 2024-05-29 Exercise |
2024-05-31 7:00 pm |
N/A 2024-07-01 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | SCHULMAN AMY W Director |
30,000 | $0 | 8,436 (Direct) |
View |
| 2024-05-29 Exercise |
2024-05-31 7:00 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | SCHULMAN AMY W Director |
30,000 | $66.83 | 8,436 (Direct) |
View |
| 2024-05-16 Option Award |
2024-05-20 4:11 pm |
2025-05-16 2034-05-16 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | PYOTT DAVID E I Director |
5,228 | $0 | 5,228 (Direct) |
View |
| 2024-05-16 Option Award |
2024-05-20 4:10 pm |
2025-05-16 2034-05-16 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | KELLOGG PETER N Director |
5,228 | $0 | 5,228 (Direct) |
View |
| 2024-05-16 Option Award |
2024-05-20 4:09 pm |
2025-05-16 2034-05-16 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Bertozzi Carolyn R Director |
5,228 | $0 | 5,228 (Direct) |
View |
| 2024-05-16 Option Award |
2024-05-20 4:08 pm |
2025-05-16 2034-05-16 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Sigal Charles Elliott Director |
5,228 | $0 | 5,228 (Direct) |
View |
| 2024-05-16 Option Award |
2024-05-20 4:07 pm |
2025-05-16 2034-05-16 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | BRANDICOURT OLIVIER Director |
5,228 | $0 | 5,228 (Direct) |
View |
| 2024-05-16 Option Award |
2024-05-20 4:06 pm |
2025-05-16 2034-05-16 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | HAMBURG MARGARET A Director |
5,228 | $0 | 5,228 (Direct) |
View |
| 2024-05-16 Option Award |
2024-05-20 4:06 pm |
2025-05-16 2034-05-16 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Reitan Colleen F Director |
5,228 | $0 | 5,228 (Direct) |
View |
| 2024-05-16 Option Award |
2024-05-20 4:05 pm |
2025-05-16 2034-05-16 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | BONNEY MICHAEL W Director |
5,228 | $0 | 5,228 (Direct) |
View |
| 2024-05-16 Option Award |
2024-05-20 4:04 pm |
2025-05-16 2034-05-16 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | SCHULMAN AMY W Director |
5,228 | $0 | 5,228 (Direct) |
View |
| 2024-05-16 Option Award |
2024-05-20 4:03 pm |
2025-05-16 2034-05-16 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Ausiello Dennis A Director |
5,228 | $0 | 5,228 (Direct) |
View |
| 2024-05-16 Option Award |
2024-05-20 4:02 pm |
2025-05-16 2034-05-16 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | SHARP PHILLIP A Director |
5,228 | $0 | 5,228 (Direct) |
View |
Ownership |
2024-03-28 4:17 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Fitzgerald Kevin Joseph CSO & EVP, Head of Research |
0 | $0 | 124,620 (Direct) |
View |
| 2024-03-01 Option Award |
2024-03-05 4:22 pm |
N/A 2034-03-01 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Tanguler Tolga EVP, Chief Commercial Officer |
14,030 | $0 | 19,266 (Direct) |
View |
| 2024-03-01 Option Award |
2024-03-05 4:21 pm |
N/A 2034-03-01 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs |
14,030 | $0 | 23,377 (Direct) |
View |
| 2024-03-01 Option Award |
2024-03-05 4:21 pm |
N/A 2034-03-01 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer |
22,859 | $0 | 42,394 (Direct) |
View |
| 2024-03-01 Option Award |
2024-03-05 4:20 pm |
N/A 2034-03-01 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer |
70,148 | $0 | 118,683 (Direct) |
View |
| 2024-02-29 Exercise |
2024-03-01 4:12 pm |
2015-06-05 2024-06-04 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | SHARP PHILLIP A Director |
30,000 | $0 | 266,899 (Direct) |
View |
| 2024-02-29 Exercise |
2024-03-01 4:12 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | SHARP PHILLIP A Director |
30,000 | $59.25 | 266,899 (Direct) |
View |
| 2024-02-27 Exercise |
2024-02-29 4:18 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Tanguler Tolga EVP, Chief Commercial Officer |
1,667 | $0 | 8,569 (Direct) |
View |
| 2024-02-27 Exercise |
2024-02-29 4:18 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer |
1,908 | $0 | 23,351 (Direct) |
View |
| 2024-02-27 Exercise |
2024-02-29 4:18 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer |
5,921 | $0 | 60,377 (Direct) |
View |
| 2024-02-27 Exercise |
2024-02-29 4:17 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs |
1,908 | $0 | 13,163 (Direct) |
View |
| 2024-02-27 Exercise |
2024-02-29 4:16 pm |
N/A 2026-02-27 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Franchini Indrani Lall EVP, CLO & Secretary |
878 | $0 | 5,887 (Direct) |
View |
| 2024-02-15 Option Award |
2024-02-20 4:09 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs |
4,295 | $0 | 8,013 (Direct) |
View |
| 2024-02-15 Option Award |
2024-02-20 4:08 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer |
3,278 | $0 | 18,201 (Direct) |
View |
| 2024-02-15 Option Award |
2024-02-20 4:08 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Tanguler Tolga EVP, Chief Commercial Officer |
3,278 | $0 | 4,070 (Direct) |
View |
| 2024-02-15 Option Award |
2024-02-20 4:07 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer |
16,953 | $0 | 45,546 (Direct) |
View |
| 2024-02-01 Exercise |
2024-02-05 4:05 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Franchini Indrani Lall EVP, CLO & Secretary |
5,175 | $0 | 8,759 (Direct) |
View |
| 2023-12-27 Exercise |
2023-12-29 4:03 pm |
N/A 2024-12-17 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | BONNEY MICHAEL W Director |
30,000 | $0 | 20,029 (Direct) |
View |
| 2023-12-27 Exercise |
2023-12-29 4:03 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | BONNEY MICHAEL W Director |
30,000 | $96.45 | 20,029 (Direct) |
View |
| 2023-08-03 Option Award |
2023-08-07 6:05 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs |
7,627 | $0 | 5,026 (Direct) |
View |
| 2023-08-03 Option Award |
2023-08-07 6:05 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer |
7,627 | $0 | 15,930 (Direct) |
View |
| 2023-08-03 Option Award |
2023-08-07 6:04 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer |
8,941 | $0 | 35,623 (Direct) |
View |
| 2023-08-03 Option Award |
2023-08-07 6:04 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Vaishnaw Akshay President |
8,941 | $0 | 23,289 (Direct) |
View |
| 2023-08-02 Exercise |
2023-08-04 4:02 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | BONNEY MICHAEL W Director |
22,477 | $0 | 20,029 (Direct) |
View |
| 2023-05-18 Option Award |
2023-05-19 4:06 pm |
2024-05-18 2033-05-18 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | PYOTT DAVID E I Director |
3,454 | $0 | 3,454 (Direct) |
View |
| 2023-05-18 Option Award |
2023-05-19 4:06 pm |
2024-05-18 2033-05-18 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Sigal Charles Elliott Director |
3,454 | $0 | 3,454 (Direct) |
View |
| 2023-05-18 Option Award |
2023-05-19 4:06 pm |
2024-05-18 2033-05-18 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | BRANDICOURT OLIVIER Director |
3,454 | $0 | 3,454 (Direct) |
View |
| 2023-05-18 Option Award |
2023-05-19 4:05 pm |
2024-05-18 2033-05-18 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | HAMBURG MARGARET A Director |
3,454 | $0 | 3,454 (Direct) |
View |
| 2023-05-18 Option Award |
2023-05-19 4:05 pm |
2024-05-18 2033-05-18 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Reitan Colleen F Director |
3,454 | $0 | 3,454 (Direct) |
View |